These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 22196477)

  • 41. Clinical Characterization and Treatment Patterns for the Frequent Exacerbator Phenotype in Chronic Obstructive Pulmonary Disease with Severe or Very Severe Airflow Limitation.
    Blasi F; Neri L; Centanni S; Falcone F; Di Maria G
    COPD; 2017 Feb; 14(1):15-22. PubMed ID: 27824270
    [TBL] [Abstract][Full Text] [Related]  

  • 42. COPD phenotypes: differences in survival.
    Hernández Vázquez J; Ali García I; Jiménez-García R; Álvaro Meca A; López de Andrés A; Matesanz Ruiz C; Buendía García MJ; de Miguel Díez J
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2245-2251. PubMed ID: 30050297
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacological treatment of chronic obstructive pulmonary disease: from evidence-based medicine to phenotyping.
    Montuschi P; Malerba M; Santini G; Miravitlles M
    Drug Discov Today; 2014 Dec; 19(12):1928-35. PubMed ID: 25182512
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical analysis of chronic obstructive pulmonary disease phenotypes classified using high-resolution computed tomography.
    Fujimoto K; Kitaguchi Y; Kubo K; Honda T
    Respirology; 2006 Nov; 11(6):731-40. PubMed ID: 17052301
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic Obstructive Pulmonary Disease: official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented care.
    Koblizek V; Chlumsky J; Zindr V; Neumannova K; Zatloukal J; Zak J; Sedlak V; Kocianova J; Zatloukal J; Hejduk K; Pracharova S;
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Jun; 157(2):189-201. PubMed ID: 23733084
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Phenotypes in chronic obstructive pulmonary disease].
    Corhay JL; Schleich F; Louis R
    Rev Med Liege; 2014; 69(7-8):415-21. PubMed ID: 25158382
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetics of COPD.
    Molfino NA
    Chest; 2004 May; 125(5):1929-40. PubMed ID: 15136409
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [PERSONALIZED MEDICINE: CHRONIC OBSTRUCTIVE PULMONARY DISEASE TREATMENT].
    Corhay JL
    Rev Med Liege; 2015; 70(5-6):310-5. PubMed ID: 26285458
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Phenotype specific therapy of COPD].
    Rothe T
    Praxis (Bern 1994); 2014 Dec; 103(25):1509-14. PubMed ID: 25491053
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic obstructive pulmonary disease and bronchiectasis.
    Novosad SA; Barker AF
    Curr Opin Pulm Med; 2013 Mar; 19(2):133-9. PubMed ID: 23287285
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Chronic obstructive pulmonary disease phenotypes and the related characteristics of treatment response].
    Pan MM; Sun TY; Wang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Apr; 36(4):293-6. PubMed ID: 23945345
    [No Abstract]   [Full Text] [Related]  

  • 52. ACO: Time to move from the description of different phenotypes to the treatable traits.
    Toledo-Pons N; van Boven JFM; Román-Rodríguez M; Pérez N; Valera Felices JL; Soriano JB; Cosío BG
    PLoS One; 2019; 14(1):e0210915. PubMed ID: 30677059
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phenotypes and disease characterization in chronic obstructive pulmonary disease. Toward the extinction of phenotypes?
    Agustí A
    Ann Am Thorac Soc; 2013 Dec; 10 Suppl():S125-30. PubMed ID: 24313762
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chronic obstructive pulmonary disease.
    Decramer M; Janssens W; Miravitlles M
    Lancet; 2012 Apr; 379(9823):1341-51. PubMed ID: 22314182
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Spanish COPD Guidelines (GesEPOC): Pharmacological treatment of stable COPD].
    Miravitlles M; Soler-Cataluña JJ; Calle M; Molina J; Almagro P; Quintano JA; Riesco JA; Trigueros JA; Piñera P; Simón A; López-Campos JL; Soriano JB; Ancochea J
    Aten Primaria; 2012 Jul; 44(7):425-37. PubMed ID: 22704760
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Treatment of bronchial asthma and COPD].
    Rothe T
    Ther Umsch; 2014 May; 71(5):282-7. PubMed ID: 24794338
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Estimating the prevalence of phenotypes in patients with pulmonary obstructive disease. ADEPOCLE study].
    De Abajo Larriba AB; Méndez Rodríguez E; González-Gallego J; Capón Álvarez J; Díaz Rodríguez Á; Peleteiro Cobo B; Mahmoud Atoui O; De Abajo Olea S; Lumbreras González V; Martínez de Mandojana Hernández J
    Nutr Hosp; 2017 Feb; 34(1):180-185. PubMed ID: 28244790
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical phenotypes in chronic obstructive pulmonary disease].
    Silva RO
    Rev Med Chil; 2012 Jul; 140(7):926-33. PubMed ID: 23282708
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Personalised Medicine for Asthma and Chronic Obstructive Pulmonary Disease.
    Heaney LG; McGarvey LP
    Respiration; 2017; 93(3):153-161. PubMed ID: 28110335
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bronchiectasis in COPD patients: more than a comorbidity?
    Martinez-Garcia MA; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1401-1411. PubMed ID: 28546748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.